Bioavailability enhancement and neuropharmacological effects of Dauricine under intranasal administration to improve cognitive impairment via PI3K/AKT/mTOR pathway.
Saved in:
| Title: | Bioavailability enhancement and neuropharmacological effects of Dauricine under intranasal administration to improve cognitive impairment via PI3K/AKT/mTOR pathway. |
|---|---|
| Authors: | Xie R; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China., Liu Z; Department of Chemistry & the MOE Key Laboratory of Spectrochemical Analysis and Instrumentation, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, 361005, China., Zheng J; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China., Tan Q; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China., Wu H; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China., Liang Y; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. liangyong@gzucm.edu.cn.; Department of Chemistry & the MOE Key Laboratory of Spectrochemical Analysis and Instrumentation, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, 361005, China. liangyong@gzucm.edu.cn. |
| Source: | Drug delivery and translational research [Drug Deliv Transl Res] 2026 May; Vol. 16 (5), pp. 1607-1628. Date of Electronic Publication: 2025 Sep 19. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101540061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2190-3948 (Electronic) Linking ISSN: 2190393X NLM ISO Abbreviation: Drug Deliv Transl Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40973891 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Bioavailability enhancement and neuropharmacological effects of Dauricine under intranasal administration to improve cognitive impairment via PI3K/AKT/mTOR pathway. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Xie+R%22">Xie R</searchLink>; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.<br /><searchLink fieldCode="AU" term="%22Liu+Z%22">Liu Z</searchLink>; Department of Chemistry & the MOE Key Laboratory of Spectrochemical Analysis and Instrumentation, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, 361005, China.<br /><searchLink fieldCode="AU" term="%22Zheng+J%22">Zheng J</searchLink>; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.<br /><searchLink fieldCode="AU" term="%22Tan+Q%22">Tan Q</searchLink>; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.<br /><searchLink fieldCode="AU" term="%22Wu+H%22">Wu H</searchLink>; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.<br /><searchLink fieldCode="AU" term="%22Liang+Y%22">Liang Y</searchLink>; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. liangyong@gzucm.edu.cn.; Department of Chemistry & the MOE Key Laboratory of Spectrochemical Analysis and Instrumentation, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, 361005, China. liangyong@gzucm.edu.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101540061%22">Drug delivery and translational research</searchLink> [Drug Deliv Transl Res] 2026 May; Vol. 16 (5), pp. 1607-1628. <i>Date of Electronic Publication: </i>2025 Sep 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101540061 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2190-3948 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222190393X%22">2190393X </searchLink><i>NLM ISO Abbreviation: </i>Drug Deliv Transl Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40973891 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s13346-025-01975-w Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1607 Titles: – TitleFull: Bioavailability enhancement and neuropharmacological effects of Dauricine under intranasal administration to improve cognitive impairment via PI3K/AKT/mTOR pathway. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Xie R – PersonEntity: Name: NameFull: Liu Z – PersonEntity: Name: NameFull: Zheng J – PersonEntity: Name: NameFull: Tan Q – PersonEntity: Name: NameFull: Wu H – PersonEntity: Name: NameFull: Liang Y IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2190-3948 Numbering: – Type: volume Value: 16 – Type: issue Value: 5 Titles: – TitleFull: Drug delivery and translational research Type: main |
| ResultId | 1 |
